Clinical Trials Browser

Central Nervous System Neoplasms × Ferrosoferric Oxide × 1 year × Clear all

NCT03270059 2026-02-27

Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System

Phase 2 Recruiting

Brain Neoplasms, Cranial Nerve Diseases, Central Nervous System Neoplasms